Impact of lipodystrophy on health-related quality of life: the QuaLip study

被引：0

作者：

Tevfik Demir

Ilgin Yildirim Simsir

Ozlem Kuman Tuncel

Burcu Ozbaran

Ilker Yildirim

Sebnem Pirildar

Samim Ozen

Baris Akinci

机构：

[1] Dokuz Eylul University,Division of Endocrinology and Metabolism, Department of Internal Medicine

[2] Ege University,Division of Endocrinology and Metabolism, Department of Internal Medicine

[3] Ege University,Department of Psychiatry

[4] Ege University,Department of Child and Adolescent Psychiatry

[5] Amryt Pharmaceuticals,Division of Pediatric Endocrinology and Metabolism

[6] Ege University,undefined

[7] Depark,undefined

[8] Dokuz Eylul University,undefined

[9] Izmir Biomedicine and Genome Center,undefined

来源：

Orphanet Journal of Rare Diseases | / 19卷

关键词：

Lipodystrophy; Quality of life; Psychiatric disease; Appetite; Emotional well-being;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 148 条

[1] Akinci B(2018)Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities Curr Diab Rep 18 143-797
[2] Meral R(2016)Lipodystrophy syndromes Endocrinol Metab Clin North Am 45 783-416
[3] Oral EA(2000)Lipoatrophy revisited Trends Endocrinol Metab 11 410-333
[4] Hussain I(2010)Rationale for leptin-replacement therapy for severe lipodystrophy Endocr Pract 16 324-5135
[5] Garg A(2019)Comorbidities and survival in patients with lipodystrophy: an international chart review study J Clin Endocrinol Metab 104 5120-2767
[6] Reitman ML(2016)Natural history of congenital generalized lipodystrophy: a nationwide study from Turkey J Clin Endocrinol Metab 101 2759-280
[7] Arioglu E(2018)Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy PLoS ONE 13 e0199052-4511
[8] Gavrilova O(2015)Estimating quality of life of patients with lipodystrophy Value Health 18 A292-1968
[9] Taylor SI(2021)Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy J Endocr Soc 5 bvab019-693
[10] Oral EA(2020)Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy Natl Med J India 33 278-62